Step 1: Timolol is a topical non-selective beta blocker that lowers intraocular pressure by reducing aqueous humor production by the ciliary body.
Step 2: Its key advantage over older miotic agents such as pilocarpine is that it does not change pupil size. It produces no miosis, so there is no fluctuation in intraocular tension, no induced myopia and no ciliary spasm or spasm of accommodation, making it more comfortable and convenient for once or twice daily use.
Step 3: Why the others are wrong - timolol works by decreasing aqueous formation, not by increasing outflow. It is a non-selective beta blocker, not a selective one. Although timolol has weak membrane stabilizing potential, this is not the clinical reason it is preferred for glaucoma.
Answer: Produces no miosis.